Loading…

Incident rates of colonic neoplasia in older patients: When should we stop screening?

Introduction:  Current guidelines endorse colon cancer screening every 5–10 years in patients over 50 years of age. However, there is no consensus regarding what age is appropriate to stop screening. The aim of this study was to characterize neoplasia occurrence/recurrence in a large cohort of patie...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastroenterology and hepatology 2006-06, Vol.21 (6), p.1021-1025
Main Authors: Harewood, Gavin C, Lawlor, Garrett O, Larson, Mark V
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5018-3c73f4439d740928a38e2d87ed96a6687ccca5651efb5e73f52393367fcd05a83
cites cdi_FETCH-LOGICAL-c5018-3c73f4439d740928a38e2d87ed96a6687ccca5651efb5e73f52393367fcd05a83
container_end_page 1025
container_issue 6
container_start_page 1021
container_title Journal of gastroenterology and hepatology
container_volume 21
creator Harewood, Gavin C
Lawlor, Garrett O
Larson, Mark V
description Introduction:  Current guidelines endorse colon cancer screening every 5–10 years in patients over 50 years of age. However, there is no consensus regarding what age is appropriate to stop screening. The aim of this study was to characterize neoplasia occurrence/recurrence in a large cohort of patients ≥70 years of age undergoing colonoscopy. Methods:  The Mayo Rochester endoscopic database was reviewed to determine the incidence of colonic neoplasia in patients ≥70 years undergoing two colonoscopies at least 12 months apart between January 1996 and December 2000. Patients were classified based on (i) age: 70–74, 75–79, ≥80 years; and (ii) polyp detection on initial examination, that is, subsequent examination for screening or surveillance. Results:  Overall, 1353 patients underwent two colonoscopies at least 12 months apart (median interval 140 weeks) with removal of polyp on initial examination in 726 (53.7%) patients (surveillance cohort). On subsequent endoscopy, polyps ≥10 mm were detected in 54 (4.0%) and cancer in 13 (1.0%) patients. All age groups were well matched with respect to detection of neoplasia on index examination (P = 0.9) and polyp size on initial colonoscopy among the surveillance group (P = 0.9). Using a Cox proportional hazards model, adjusted hazard ratios (95% confidence interval [CI]) for neoplasia (polyps ≥10 mm) were: 2.0 (1.50–2.73, P 
doi_str_mv 10.1111/j.1440-1746.2006.04218.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68013367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68013367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5018-3c73f4439d740928a38e2d87ed96a6687ccca5651efb5e73f52393367fcd05a83</originalsourceid><addsrcrecordid>eNqNkE1v1DAQhi0EokvhLyBf4JZgx99ICJXSbotWICSqHi3XmVAv2TjYWXX77-uwq_aKL7Y0z-uZeRDClNS0nA_rmnJOKqq4rBtCZE14Q3W9e4YWj4XnaEE0FZVh1ByhVzmvCSGcKPESHVGpGm60WaCry8GHFoYJJzdBxrHDPvZxCB4PEMfe5eBwGHDsW0h4dFMobP6Ir29hwPk2bvsW3wHOUxxx9glgCMPvz6_Ri871Gd4c7mN0dX726_SiWv1YXp6erCovCNUV84p1nDPTKk5Mox3T0LRaQWukk1Ir770TUlDobgQUVjTMMCZV51sinGbH6P3-3zHFv1vIk92E7KHvXRl-m63UhM58AfUe9CnmnKCzYwobl-4tJXZWatd2Nmdnc3ZWav8ptbsSfXvosb3ZQPsUPDgswLsD4LJ3fZdcUZqfOKXNrL1wn_bcXejh_r8HsN-WF_Or5Kt9PuQJdo95l_7YsqES9vr70n6RevVV_Dy3nD0AtwmgMw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68013367</pqid></control><display><type>article</type><title>Incident rates of colonic neoplasia in older patients: When should we stop screening?</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Harewood, Gavin C ; Lawlor, Garrett O ; Larson, Mark V</creator><creatorcontrib>Harewood, Gavin C ; Lawlor, Garrett O ; Larson, Mark V</creatorcontrib><description>Introduction:  Current guidelines endorse colon cancer screening every 5–10 years in patients over 50 years of age. However, there is no consensus regarding what age is appropriate to stop screening. The aim of this study was to characterize neoplasia occurrence/recurrence in a large cohort of patients ≥70 years of age undergoing colonoscopy. Methods:  The Mayo Rochester endoscopic database was reviewed to determine the incidence of colonic neoplasia in patients ≥70 years undergoing two colonoscopies at least 12 months apart between January 1996 and December 2000. Patients were classified based on (i) age: 70–74, 75–79, ≥80 years; and (ii) polyp detection on initial examination, that is, subsequent examination for screening or surveillance. Results:  Overall, 1353 patients underwent two colonoscopies at least 12 months apart (median interval 140 weeks) with removal of polyp on initial examination in 726 (53.7%) patients (surveillance cohort). On subsequent endoscopy, polyps ≥10 mm were detected in 54 (4.0%) and cancer in 13 (1.0%) patients. All age groups were well matched with respect to detection of neoplasia on index examination (P = 0.9) and polyp size on initial colonoscopy among the surveillance group (P = 0.9). Using a Cox proportional hazards model, adjusted hazard ratios (95% confidence interval [CI]) for neoplasia (polyps ≥10 mm) were: 2.0 (1.50–2.73, P &lt; 0.0001) (surveillance vs screening), 1.33 (0.96–1.79, P = 0.08) (≥80 vs 70–74), and 1.05 (0.78–1.38, P = 0.75) (75–79 vs 70–74). Adjusted hazard ratios for development of cancer were: 1.87 (1.03–3.97, P = 0.04) (surveillance vs screening), 1.73 (0.84–3.56, P = 0.13) (≥80 vs 70–74), and 1.38 (0.71–2.77, P = 0.34) (75–79 vs 70–74). Conclusions:  Prior history of neoplasia remains a strong risk factor for colorectal neoplasia development in elderly patients and should be considered when deciding the need for continuing screening/surveillance. Incident neoplasia rates in a previously screened elderly population rise slowly with advancing age although cancer rates rise more sharply. Therefore, screening still retains a role in elderly patients; however, clinical judgment is still required to individualize screening practice. As the risk of competing comorbid illnesses continues to increase over time, the threshold to perform colon screening should increase accordingly.</description><identifier>ISSN: 0815-9319</identifier><identifier>EISSN: 1440-1746</identifier><identifier>DOI: 10.1111/j.1440-1746.2006.04218.x</identifier><identifier>PMID: 16724989</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Aged ; Aged, 80 and over ; Biological and medical sciences ; Colonic Neoplasms - diagnosis ; Colonic Neoplasms - epidemiology ; Colonoscopy ; colorectal cancer ; Digestive system. Abdomen ; Endoscopy ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Incidence ; Investigative techniques, diagnostic techniques (general aspects) ; Male ; Mass Screening ; Medical sciences ; screening ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tumors</subject><ispartof>Journal of gastroenterology and hepatology, 2006-06, Vol.21 (6), p.1021-1025</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5018-3c73f4439d740928a38e2d87ed96a6687ccca5651efb5e73f52393367fcd05a83</citedby><cites>FETCH-LOGICAL-c5018-3c73f4439d740928a38e2d87ed96a6687ccca5651efb5e73f52393367fcd05a83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17894075$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16724989$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harewood, Gavin C</creatorcontrib><creatorcontrib>Lawlor, Garrett O</creatorcontrib><creatorcontrib>Larson, Mark V</creatorcontrib><title>Incident rates of colonic neoplasia in older patients: When should we stop screening?</title><title>Journal of gastroenterology and hepatology</title><addtitle>J Gastroenterol Hepatol</addtitle><description>Introduction:  Current guidelines endorse colon cancer screening every 5–10 years in patients over 50 years of age. However, there is no consensus regarding what age is appropriate to stop screening. The aim of this study was to characterize neoplasia occurrence/recurrence in a large cohort of patients ≥70 years of age undergoing colonoscopy. Methods:  The Mayo Rochester endoscopic database was reviewed to determine the incidence of colonic neoplasia in patients ≥70 years undergoing two colonoscopies at least 12 months apart between January 1996 and December 2000. Patients were classified based on (i) age: 70–74, 75–79, ≥80 years; and (ii) polyp detection on initial examination, that is, subsequent examination for screening or surveillance. Results:  Overall, 1353 patients underwent two colonoscopies at least 12 months apart (median interval 140 weeks) with removal of polyp on initial examination in 726 (53.7%) patients (surveillance cohort). On subsequent endoscopy, polyps ≥10 mm were detected in 54 (4.0%) and cancer in 13 (1.0%) patients. All age groups were well matched with respect to detection of neoplasia on index examination (P = 0.9) and polyp size on initial colonoscopy among the surveillance group (P = 0.9). Using a Cox proportional hazards model, adjusted hazard ratios (95% confidence interval [CI]) for neoplasia (polyps ≥10 mm) were: 2.0 (1.50–2.73, P &lt; 0.0001) (surveillance vs screening), 1.33 (0.96–1.79, P = 0.08) (≥80 vs 70–74), and 1.05 (0.78–1.38, P = 0.75) (75–79 vs 70–74). Adjusted hazard ratios for development of cancer were: 1.87 (1.03–3.97, P = 0.04) (surveillance vs screening), 1.73 (0.84–3.56, P = 0.13) (≥80 vs 70–74), and 1.38 (0.71–2.77, P = 0.34) (75–79 vs 70–74). Conclusions:  Prior history of neoplasia remains a strong risk factor for colorectal neoplasia development in elderly patients and should be considered when deciding the need for continuing screening/surveillance. Incident neoplasia rates in a previously screened elderly population rise slowly with advancing age although cancer rates rise more sharply. Therefore, screening still retains a role in elderly patients; however, clinical judgment is still required to individualize screening practice. As the risk of competing comorbid illnesses continues to increase over time, the threshold to perform colon screening should increase accordingly.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Colonic Neoplasms - diagnosis</subject><subject>Colonic Neoplasms - epidemiology</subject><subject>Colonoscopy</subject><subject>colorectal cancer</subject><subject>Digestive system. Abdomen</subject><subject>Endoscopy</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Incidence</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Medical sciences</subject><subject>screening</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tumors</subject><issn>0815-9319</issn><issn>1440-1746</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNkE1v1DAQhi0EokvhLyBf4JZgx99ICJXSbotWICSqHi3XmVAv2TjYWXX77-uwq_aKL7Y0z-uZeRDClNS0nA_rmnJOKqq4rBtCZE14Q3W9e4YWj4XnaEE0FZVh1ByhVzmvCSGcKPESHVGpGm60WaCry8GHFoYJJzdBxrHDPvZxCB4PEMfe5eBwGHDsW0h4dFMobP6Ir29hwPk2bvsW3wHOUxxx9glgCMPvz6_Ri871Gd4c7mN0dX726_SiWv1YXp6erCovCNUV84p1nDPTKk5Mox3T0LRaQWukk1Ir770TUlDobgQUVjTMMCZV51sinGbH6P3-3zHFv1vIk92E7KHvXRl-m63UhM58AfUe9CnmnKCzYwobl-4tJXZWatd2Nmdnc3ZWav8ptbsSfXvosb3ZQPsUPDgswLsD4LJ3fZdcUZqfOKXNrL1wn_bcXejh_r8HsN-WF_Or5Kt9PuQJdo95l_7YsqES9vr70n6RevVV_Dy3nD0AtwmgMw</recordid><startdate>200606</startdate><enddate>200606</enddate><creator>Harewood, Gavin C</creator><creator>Lawlor, Garrett O</creator><creator>Larson, Mark V</creator><general>Blackwell Publishing Asia</general><general>Blackwell Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200606</creationdate><title>Incident rates of colonic neoplasia in older patients: When should we stop screening?</title><author>Harewood, Gavin C ; Lawlor, Garrett O ; Larson, Mark V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5018-3c73f4439d740928a38e2d87ed96a6687ccca5651efb5e73f52393367fcd05a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Colonic Neoplasms - diagnosis</topic><topic>Colonic Neoplasms - epidemiology</topic><topic>Colonoscopy</topic><topic>colorectal cancer</topic><topic>Digestive system. Abdomen</topic><topic>Endoscopy</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Incidence</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Medical sciences</topic><topic>screening</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harewood, Gavin C</creatorcontrib><creatorcontrib>Lawlor, Garrett O</creatorcontrib><creatorcontrib>Larson, Mark V</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harewood, Gavin C</au><au>Lawlor, Garrett O</au><au>Larson, Mark V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incident rates of colonic neoplasia in older patients: When should we stop screening?</atitle><jtitle>Journal of gastroenterology and hepatology</jtitle><addtitle>J Gastroenterol Hepatol</addtitle><date>2006-06</date><risdate>2006</risdate><volume>21</volume><issue>6</issue><spage>1021</spage><epage>1025</epage><pages>1021-1025</pages><issn>0815-9319</issn><eissn>1440-1746</eissn><abstract>Introduction:  Current guidelines endorse colon cancer screening every 5–10 years in patients over 50 years of age. However, there is no consensus regarding what age is appropriate to stop screening. The aim of this study was to characterize neoplasia occurrence/recurrence in a large cohort of patients ≥70 years of age undergoing colonoscopy. Methods:  The Mayo Rochester endoscopic database was reviewed to determine the incidence of colonic neoplasia in patients ≥70 years undergoing two colonoscopies at least 12 months apart between January 1996 and December 2000. Patients were classified based on (i) age: 70–74, 75–79, ≥80 years; and (ii) polyp detection on initial examination, that is, subsequent examination for screening or surveillance. Results:  Overall, 1353 patients underwent two colonoscopies at least 12 months apart (median interval 140 weeks) with removal of polyp on initial examination in 726 (53.7%) patients (surveillance cohort). On subsequent endoscopy, polyps ≥10 mm were detected in 54 (4.0%) and cancer in 13 (1.0%) patients. All age groups were well matched with respect to detection of neoplasia on index examination (P = 0.9) and polyp size on initial colonoscopy among the surveillance group (P = 0.9). Using a Cox proportional hazards model, adjusted hazard ratios (95% confidence interval [CI]) for neoplasia (polyps ≥10 mm) were: 2.0 (1.50–2.73, P &lt; 0.0001) (surveillance vs screening), 1.33 (0.96–1.79, P = 0.08) (≥80 vs 70–74), and 1.05 (0.78–1.38, P = 0.75) (75–79 vs 70–74). Adjusted hazard ratios for development of cancer were: 1.87 (1.03–3.97, P = 0.04) (surveillance vs screening), 1.73 (0.84–3.56, P = 0.13) (≥80 vs 70–74), and 1.38 (0.71–2.77, P = 0.34) (75–79 vs 70–74). Conclusions:  Prior history of neoplasia remains a strong risk factor for colorectal neoplasia development in elderly patients and should be considered when deciding the need for continuing screening/surveillance. Incident neoplasia rates in a previously screened elderly population rise slowly with advancing age although cancer rates rise more sharply. Therefore, screening still retains a role in elderly patients; however, clinical judgment is still required to individualize screening practice. As the risk of competing comorbid illnesses continues to increase over time, the threshold to perform colon screening should increase accordingly.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>16724989</pmid><doi>10.1111/j.1440-1746.2006.04218.x</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0815-9319
ispartof Journal of gastroenterology and hepatology, 2006-06, Vol.21 (6), p.1021-1025
issn 0815-9319
1440-1746
language eng
recordid cdi_proquest_miscellaneous_68013367
source Wiley-Blackwell Read & Publish Collection
subjects Aged
Aged, 80 and over
Biological and medical sciences
Colonic Neoplasms - diagnosis
Colonic Neoplasms - epidemiology
Colonoscopy
colorectal cancer
Digestive system. Abdomen
Endoscopy
Female
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Incidence
Investigative techniques, diagnostic techniques (general aspects)
Male
Mass Screening
Medical sciences
screening
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Tumors
title Incident rates of colonic neoplasia in older patients: When should we stop screening?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T18%3A48%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incident%20rates%20of%20colonic%20neoplasia%20in%20older%20patients:%20When%20should%20we%20stop%20screening?&rft.jtitle=Journal%20of%20gastroenterology%20and%20hepatology&rft.au=Harewood,%20Gavin%20C&rft.date=2006-06&rft.volume=21&rft.issue=6&rft.spage=1021&rft.epage=1025&rft.pages=1021-1025&rft.issn=0815-9319&rft.eissn=1440-1746&rft_id=info:doi/10.1111/j.1440-1746.2006.04218.x&rft_dat=%3Cproquest_cross%3E68013367%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5018-3c73f4439d740928a38e2d87ed96a6687ccca5651efb5e73f52393367fcd05a83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68013367&rft_id=info:pmid/16724989&rfr_iscdi=true